摘要
目的研究巨噬细胞移动抑制因子(MIF)在老年肾病综合征合并脑梗死患者判断价值与临床应用。方法分析84例肾病综合征患者的临床资料,将其中合并患有脑梗死的40例患者列为观察组,仅患有肾病综合征的44例患者划为对照组。采用双夹心酶联免疫吸附试验测定MIF在老年肾病综合征合并脑梗死患者的血清水平。结果观察组患者血清中三酰甘油(TG)含量明显高于对照组,差异有统计学意义(t=2.792,P=0.007),两组研究对象在总胆固醇(TC)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)水平比较上,差异无统计学意义(P>0.05);观察组患者血清中同型半胱氨酸(Hcy)(t=2.601,P=0.011)、MIF(t=2.973,P=0.004)、超敏C反应蛋白(hs-CRP)(t=2.143,P=0.035)指标水平高于对照组,差异有统计学意义(P<0.05);观察组患者TG与Hcy(r=0.365,P=0.020)、MIF(r=0.477,P=0.002)、hs-CRP(r=0.357,P=0.024)呈正相关;当MIF取值为0.856μg/L时对肾病综合征合并脑梗死的诊断敏感性为92.52%,特异性为88.64%。结论 MIF可以作为判诊断肾病综合征合并脑梗死患者的有效指标。
Objective To study the clinical application of MIF in the diagnosis of elderly nephrotic syndrome patients with cerebral infarction.Methods Clinical data of 84 patients with nephrotic syndrome were analyzed,ne-phrotic syndrome patients with cerebral infarction as the observation group,patients with nephrotic syndrome as con-trol group.MIF were measured by ABC-ELISA.Results The TG in the observation group was significantly higher than that in control group(t =2.792,P =0.007).No significant difference was found between the two groups in TC, HDL and LDL-C (P 〉0.05).Serum Hcy (t =2.601,P =0.011),MIF (t =2.973,P =0.004),and hs-CRP(t =2.143,P =0.035)in the observation group were higher than those in control group,a statistically significant differ-ence (P 〈0.05).TG had a positive correlation with Hcy (r =0.365,P =0.020),MIF(r =0.477,P =0.002), hs-CRP(r =0.357,P =0.024)in observation group.When the MIF value was 0.856 μg/L,the sensitivity of the di-agnosis of nephrotic syndrome with cerebral infarction was 92.52%,specificity was 88.64%.Conclusions MIF can be used as a effective index in the clinical diagnosis of nephrotic syndrome patients with cerebral infarction.
出处
《中国临床保健杂志》
CAS
2016年第4期392-394,共3页
Chinese Journal of Clinical Healthcare
关键词
肾病综合征
脑梗死
巨噬细胞移动抑制因子
Nephrotic syndrome
Cerebral infarction
Macrophage migration inhibitory factor